Luxury Time Ltd. IPO – Allotment Status, Subscription & GMP

Luxury Time IPO Allotment

At a Glance: What You Should Know

ItemDetail
IPO NameLuxury Time Ltd.
Issue Price Band₹ 78 – ₹ 82 per equity share
Lot Size / Minimum Investment1,600 shares (minimum application ~ ₹ 1.31 lakh)
IPO SubscriptionRetail: 860.53×, NII: 677.63×, QIB: 205.58×, Overall: ≈ 635.67×
Allotment Date9 December 2025
Listing Date (Expected)11 December 2025 (on BSE SME)
RegistrarMAS Services Limited
Grey Market Premium (GMP)Approx. ₹ 90 – ₹ 98 per share (varied recently)

Subscription & Demand Overview

The IPO of Luxury Time Ltd. saw overwhelming interest across categories:

  • Retail investors subscribed ~ 860× — an extremely high demand from the smaller investor segment.
  • Non‑Institutional Investors (NII) applied ~ 678×.
  • Qualified Institutional Buyers (QIBs) applied ~ 206×.

Overall subscription stood at ~ 636×, indicating massive oversubscription. Such strong demand usually leads to allotment via a lottery or proportionate draw — meaning many retail applicants may receive only a fraction of applied shares.

How to Check Your Allotment Status

You can check whether you’ve been allotted shares by following these steps:

1. Via the IPO Registrar (MAS Services)

  • Visit the MAS Services IPO allotment page.
  • Select Luxury Time Ltd. from the list.
  • Enter PAN or DP/Client ID or Application Number, as applicable.
  • Complete the captcha and submit to view your status.

2. Via BSE (or relevant exchange)

  • Visit BSE’s IPO allotment section.
  • Under “Issue Type” choose “Equity”.
  • Pick “Luxury Time Ltd.” from the drop‑down for issue name.
  • Enter your Application Number and PAN.
  • Click “Search” to check status.

3. Via Third‑Party IPO Trackers / Apps
You may also use trusted IPO‑tracker websites or apps — just ensure they link to official registrar or BSE data before concluding.

Once allotment is confirmed:

  • Shares will be credited to your Demat account.
  • Refunds (for unsuccessful applications) will be processed shortly after.

Grey Market Premium (GMP): What It Means

  • GMP reflects the unofficial market’s perception of IPO demand and expected listing-day price.
  • A high GMP (e.g. ₹ 90–98) suggests that investors expect a listing price well above the issue price — often implying a big first-day gain.
  • Important: GMP is not official. It’s driven by demand–supply and sentiment. Sometimes actual listing price may differ significantly.

If Luxury Time’s IPO price is ₹ 82 and GMP is ₹ 90, the implied listing-price expectation becomes ~ ₹ 172. But actual performance at listing may vary — so treat GMP as a speculative indicator, not a guarantee.

What You Should Do Now

  • Check allotment status ASAP via registrar or BSE as per the steps above.
  • If allotted — watch for share credit in your Demat account.
  • If not allotted — expect refund.
  • Keep an eye on official listing date and consider GMP only as one of many factors before assuming listing-day profit.

Key Takeaways

  • The IPO of Luxury Time Ltd. was massively oversubscribed, especially by retail investors.
  • Allotment is complete; now you can check status via MAS Services or BSE.
  • GMP appears high — signalling positive sentiment — but it remains unofficial.
  • Always cross‑verify allotment status via official channels before making decisions.

Disclaimer

The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.